National Institutes of Health

National Institutes of Health is a biomedical research agency of the U.S. Department of Health and Human Services, based in Bethesda, Maryland. It is the primary U.S. government organization devoted to biomedical and health research, conducting science through the Intramural Research Program and funding external research through the Extramural Research Program. The NIH comprises 27 institutes and centers and supports about 1,200 principal investigators and more than 4,000 postdoctoral fellows across basic, translational, and clinical research. It has contributed to major advances such as vaccines and therapies and is dedicated to advancing knowledge and translating discoveries into improvements in public health. Established in 1887, NIH operates as a central hub for medical research in the United States.

Francis Collins

Director

Nick Langhals

Supervisory Program Director

Past deals in Image Recognition

Cortechs.ai

Grant in 2024
Cortechs.ai is a developer of brain image analysis software that enhances clinical insight through quantitative imaging. The company's innovative solutions are utilized by neurologists and radiologists in numerous clinics and research centers globally. Its software provides a practical and cost-effective approach to quantifying brain structures, aiding medical professionals in the evaluation of various neurological conditions, including Alzheimer's disease, multiple sclerosis, epilepsy, and traumatic brain injury. Through its advanced imaging technology, Cortechs.ai aims to improve diagnostic accuracy and treatment outcomes in the field of neurology.

Cortechs.ai

Grant in 2022
Cortechs.ai is a developer of brain image analysis software that enhances clinical insight through quantitative imaging. The company's innovative solutions are utilized by neurologists and radiologists in numerous clinics and research centers globally. Its software provides a practical and cost-effective approach to quantifying brain structures, aiding medical professionals in the evaluation of various neurological conditions, including Alzheimer's disease, multiple sclerosis, epilepsy, and traumatic brain injury. Through its advanced imaging technology, Cortechs.ai aims to improve diagnostic accuracy and treatment outcomes in the field of neurology.

Ramona

Grant in 2022
Ramona designs and manufactures a high-throughput microscopy toolset that enables cellular-level research across a wide field of view with synchronous data capture. The system relies on custom-designed control electronics and a large array of micro-cameras to deliver and process tens of gigapixels of object-specific data with high throughput, allowing users to capture, analyze, and securely store large-scale image data for faster, more informed decisions.

Enspectra Health

Grant in 2022
Enspectra Health, based in Mountain View, California, develops advanced imaging systems for medical research and diagnosis. Founded in 2012, the company has pioneered the world's first handheld multiphoton imager for human use, capable of visualizing beneath the skin in real-time. Its innovative system combines reflectance confocal and multiphoton laser scanning microscopy to generate multispectral images, enhancing dermatologists' ability to diagnose and treat skin conditions, particularly cancers. Enspectra Health delivers these imaging systems to researchers studying various tissues and has a track record of delivering such systems since its inception.

Ramona

Grant in 2021
Ramona designs and manufactures a high-throughput microscopy toolset that enables cellular-level research across a wide field of view with synchronous data capture. The system relies on custom-designed control electronics and a large array of micro-cameras to deliver and process tens of gigapixels of object-specific data with high throughput, allowing users to capture, analyze, and securely store large-scale image data for faster, more informed decisions.

Enspectra Health

Grant in 2021
Enspectra Health, based in Mountain View, California, develops advanced imaging systems for medical research and diagnosis. Founded in 2012, the company has pioneered the world's first handheld multiphoton imager for human use, capable of visualizing beneath the skin in real-time. Its innovative system combines reflectance confocal and multiphoton laser scanning microscopy to generate multispectral images, enhancing dermatologists' ability to diagnose and treat skin conditions, particularly cancers. Enspectra Health delivers these imaging systems to researchers studying various tissues and has a track record of delivering such systems since its inception.

MRIMath

Grant in 2021
MRIMath is a company focused on advancing medical imaging technology to improve cancer diagnosis, treatment response, and prognosis. It offers innovative solutions that enhance tumor identification and monitor treatment efficacy for oncologists and surgeons. By leveraging artificial intelligence, MRIMath provides a reliable and cost-effective human-AI interface that empowers healthcare professionals to detect brain tumor growth and optimize patient outcomes. In addition to its core offerings in medical imaging, MRIMath also delivers hospital care, medical device services, and general healthcare services, along with AI consulting and software solutions designed to streamline medical processes.

Xoran Technologies

Grant in 2019
Xoran Technologies designs and manufactures computed tomography imaging systems for point-of-care diagnosis. The company offers MiniCAT, a high-resolution CT system for bone window imaging of the sinuses, temporal bones, and skull base; Xoran xCAT, a mobile cone-beam CT system that delivers high-resolution 3D images; and XoranConnect, a web-based tool for viewing and archiving medical images. It also provides LuminX digital radiography systems, including an overhead robotic DR suite, a floor-mounted tube stand, and U-Arm and straight-arm configurations. Founded in 2001 and based in Ann Arbor, Michigan, Xoran focuses on patient-friendly imaging solutions designed to enable instant diagnosis at the point of care, with an emphasis on accessible, low radiation dose CT imaging to support clinicians.

Ramona

Grant in 2019
Ramona designs and manufactures a high-throughput microscopy toolset that enables cellular-level research across a wide field of view with synchronous data capture. The system relies on custom-designed control electronics and a large array of micro-cameras to deliver and process tens of gigapixels of object-specific data with high throughput, allowing users to capture, analyze, and securely store large-scale image data for faster, more informed decisions.

Ramona

Grant in 2018
Ramona designs and manufactures a high-throughput microscopy toolset that enables cellular-level research across a wide field of view with synchronous data capture. The system relies on custom-designed control electronics and a large array of micro-cameras to deliver and process tens of gigapixels of object-specific data with high throughput, allowing users to capture, analyze, and securely store large-scale image data for faster, more informed decisions.

VisionQuest Biomedical

Grant in 2018
VisionQuest Biomedical develops AI-based medical imaging solutions for eye and diabetes care. Its EyeStar software analyzes retinal images to diagnose diabetic retinopathy, while Aspire detects malarial retinopathy; the company is also developing i-RxTherm to identify early-stage diabetic disease outside the eye. The platform uses a neural network to process images captured with a smartphone-based retinal camera, enabling hospitals, clinics, and laboratories to detect diabetic peripheral neuropathy and retinopathy of prematurity earlier. The focus is on image-based technologies to improve access to care for diabetes and eye-related conditions, particularly in underserved populations.

Perceptive Navigation

Grant in 2018
Perceptive Navigation LLC is a pre-clinical stage medical device company based in Baltimore, Maryland, focused on developing innovative interventional medical devices for the image-guided surgery market. The company is known for its flagship product, Vu-Path, an intracorporeal ultrasound device that integrates front-viewing ultrasound imaging with a working portal. This unique combination allows for the precise introduction of needles, biopsy instruments, guide wires, and therapeutic agents into the body. Vu-Path aims to enhance the safety and efficacy of minimally invasive procedures across multiple medical disciplines, including radiology, cardiology, interventional oncology, and urology. Traditional imaging techniques often pose challenges such as high costs, complexity, and risks associated with patient safety. Vu-Path addresses these issues by facilitating quicker and safer access to internal organs while reducing the need for extensive training and equipment. With its patented technology, Perceptive Navigation seeks to transform the landscape of interventional medicine, improving outcomes for both patients and healthcare providers.

Modulim

Grant in 2017
Modulim is a company developing light-based imaging devices based on spatial frequency domain imaging (SFDI) for tissue and vascular assessment. The Clarifi Imaging System helps identify patients at risk of complications such as diabetic foot ulcers and potential limb loss due to compromised circulation, enabling clinicians to intervene earlier and protect limbs. The company's devices support skin assessment and treatment monitoring, providing tools to prevent, diagnose, and monitor medical skin conditions.

Ramona

Grant in 2017
Ramona designs and manufactures a high-throughput microscopy toolset that enables cellular-level research across a wide field of view with synchronous data capture. The system relies on custom-designed control electronics and a large array of micro-cameras to deliver and process tens of gigapixels of object-specific data with high throughput, allowing users to capture, analyze, and securely store large-scale image data for faster, more informed decisions.

VisionQuest Biomedical

Grant in 2016
VisionQuest Biomedical develops AI-based medical imaging solutions for eye and diabetes care. Its EyeStar software analyzes retinal images to diagnose diabetic retinopathy, while Aspire detects malarial retinopathy; the company is also developing i-RxTherm to identify early-stage diabetic disease outside the eye. The platform uses a neural network to process images captured with a smartphone-based retinal camera, enabling hospitals, clinics, and laboratories to detect diabetic peripheral neuropathy and retinopathy of prematurity earlier. The focus is on image-based technologies to improve access to care for diabetes and eye-related conditions, particularly in underserved populations.

VisionQuest Biomedical

Grant in 2015
VisionQuest Biomedical develops AI-based medical imaging solutions for eye and diabetes care. Its EyeStar software analyzes retinal images to diagnose diabetic retinopathy, while Aspire detects malarial retinopathy; the company is also developing i-RxTherm to identify early-stage diabetic disease outside the eye. The platform uses a neural network to process images captured with a smartphone-based retinal camera, enabling hospitals, clinics, and laboratories to detect diabetic peripheral neuropathy and retinopathy of prematurity earlier. The focus is on image-based technologies to improve access to care for diabetes and eye-related conditions, particularly in underserved populations.

VisionQuest Biomedical

Grant in 2015
VisionQuest Biomedical develops AI-based medical imaging solutions for eye and diabetes care. Its EyeStar software analyzes retinal images to diagnose diabetic retinopathy, while Aspire detects malarial retinopathy; the company is also developing i-RxTherm to identify early-stage diabetic disease outside the eye. The platform uses a neural network to process images captured with a smartphone-based retinal camera, enabling hospitals, clinics, and laboratories to detect diabetic peripheral neuropathy and retinopathy of prematurity earlier. The focus is on image-based technologies to improve access to care for diabetes and eye-related conditions, particularly in underserved populations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.